FindTrial
Sign In

Study on perioperative coagulation status of adenomyosis:prospective randomized controlled trial

Study on perioperative coagulation status of adenomyosis:prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112581
Enrollment
Unknown
Registered
2025-11-17
Start date
2025-11-30
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

Experiment group:GnRHa 3.65mg ip 28 day before operation+hysterectomy
Controlled group:Hysterectomy

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
30 Years to 52 Years

Inclusion criteria

Inclusion criteria: Age 30-52 years, dysmenorrhea and/or menorrhagia, color ultrasound and/or magnetic resonance imaging suggested adenomyosis, hemoglobin greater than 60g/L.

Exclusion criteria

Exclusion criteria: Complicated with endometriosis such as endometriosis cysts; Combined with other systemic diseases such as diabetes, hypertension, hyperlipidemia, autoimmune diseases, etc. Complicated with other diseases affecting coagulation function; Transfusion patients; Recent use of sex hormone therapy.

Design outcomes

Primary

MeasureTime frame
Coagulation function;—

Countries

China

Contacts

Public ContactWu Qing

Zhejiang Provincial People's Hospital

okwq31@163.com+86 151 6717 0568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026